XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2020
Sep. 30, 2019
Current Assets    
Cash and equivalents $ 2,825 $ 536
Restricted cash 92 54
Short-term investments 20 30
Trade receivables, net 2,398 2,345
Inventories 2,743 2,579
Prepaid expenses and other 891 1,119
Total Current Assets 8,969 6,664
Property, Plant and Equipment, Net 5,923 5,659
Goodwill 23,620 23,376
Developed Technology, Net 10,146 11,054
Customer Relationships, Net 3,107 3,424
Other Intangibles, Net 560 500
Other Assets 1,687 1,088
Total Assets 54,012 51,765
Current Liabilities    
Short-term debt 707 1,309
Accounts payable 1,355 1,092
Accrued expenses 2,638 2,127
Salaries, wages and related items 993 987
Income taxes 144 140
Total Current Liabilities 5,836 5,655
Long-Term Debt 17,224 18,081
Long-Term Employee Benefit Obligations 1,435 1,272
Deferred Income Taxes and Other Liabilities 5,753 5,676
Commitments and Contingencies (See Note 5)
Shareholders’ Equity    
Preferred stock 2 2
Common stock — $1 par value: authorized — 640,000,000 shares; issued — 364,639,901 shares in 2020 and 346,687,160 shares in 2019. 365 347
Capital in excess of par value 19,270 16,270
Retained earnings 12,791 12,913
Deferred compensation 23 23
Common stock in treasury — at cost — 74,622,657 shares in 2020 and 76,259,835 shares in 2019. (6,138) (6,190)
Accumulated other comprehensive loss (2,548) (2,283)
Total Shareholders’ Equity 23,765 21,081
Total Liabilities and Shareholders’ Equity $ 54,012 $ 51,765
Common stock, par value (USD per share) $ 1 $ 1
Common stock, shares authorized (shares) 640,000,000 640,000,000
Common stock, shares issued (shares) 364,639,901 346,687,160